[1]
2022. Evaluation of the use of botulinum toxin type A for strabismus regression: a systematic literature review. Research, Society and Development. 11, 10 (Jul. 2022), e244111032703. DOI:https://doi.org/10.33448/rsd-v11i10.32703.